Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
Massachusetts General Hospital
Dren Bio
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Incyte Corporation
AVM Biotechnology Inc
Children's Hospital of Philadelphia
Ohio State University Comprehensive Cancer Center
Arovella Therapeutics Ltd
St. Justine's Hospital
Georgetown University
Eastern Cooperative Oncology Group
Medical College of Wisconsin
CRISPR Therapeutics
AstraZeneca
AvenCell Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago
Vironexis Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
Karolinska University Hospital
City of Hope Medical Center
University of Nebraska
Pfizer
Thomas Jefferson University
Fate Therapeutics
Syndax Pharmaceuticals
Center for International Blood and Marrow Transplant Research
Incyte Corporation
Massachusetts General Hospital
M.D. Anderson Cancer Center
Allogene Therapeutics
BeOne Medicines
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
Penn State University
Columbia University
Ossium Health, Inc.
Ossium Health, Inc.
Zhejiang University
University of Miami
City of Hope Medical Center
Seattle Children's Hospital
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
Dana-Farber Cancer Institute
Washington University School of Medicine
Institute of Hematology & Blood Diseases Hospital, China
GeoVax, Inc.